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Abbreviations 
 
 
4-HNE 4-hydroxy-2 (E)-nonenal 
CS chondroitin sulphate 
DMEM/F-12  Dulbecco’s modified Eagle’s medium/Ham’s nutrient mixture F-12 
DMSO dimethyl sulfoxide 
FCS fetal calf serum 
FITC fluorescein isothiocyanate 
GAG   glycosaminoglycan 
GDB glucose containing modified Dulbecco’s buffer 
GS glucosamine-sulphate 
GSH reduced glutathione 
HA haemarthrosis 
LDH   lactate dehydrogenase 
LFA-1 leukocyte function associated molecule-1 
LTB-4 leukotrien B-4 
MDA malondialdehyde 
NSAID non-steroid anti-inflammatory drugs 
OA   osteoarthritis 
PAF   platelet activating factor 
PBS phosphate buffered saline 
PMA   phorbol 12-myristate 13-acetate 
PMN   polymorphonuclear leukocyte 
PRF   phenol red free 
RBC   red blood cell 
ROS   reactive oxygen species 
SOD superoxide dismutase 
SYSADOA symptomatic slow acting drugs against osteoarthritis 
TUNEL terminal deoxynucleotidyl transferase mediated 
desoxyuridinetriphosphate nick end labelling 
WBC   white blood cell 
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1. INTRODUCTION 
 
 
Joint disease affects hundreds of millions of people around the world causing pain and 
disability. The symptoms and treatment outcome significantly influence the quality of life and 
social reintegration of the patient, in addition to the considerable financial burden. In this 
regard activities aim to reveal new findings of pathogenic articular conditions such as the 
blood-induced joint destruction may have crucial clinical importance. 
Despite various clinical observations and experimental investigations the precise 
pathophysiology of haemarthrosis is still unclear. Especially its acute form has remained 
illusive even though haemarthrosis more frequently presents as an acute, single episode of 
intraarticular haemorrhage as a result of sport injuries or other accidents. Moreover, the 
increasing popularity of rigorous sports and other out-door recreational activities potentially 
increases the incidence of acute haemarthrosis, an indication of growing risk for the whole 
population. 
Interest in free radicals and reactive oxygen species (ROS) dates back to middle of 
20th century. Numerous in vitro and in vivo investigations were performed to reveal their role 
on many fields of biology. 
Although the pathogenic role of free radicals and ROS were widely examined in 
different articular diseases, relatively little evidence was found regarding their harmful effect 
in haemarthrosis. On the other hand only few studies have investigated the role of 
polymorphonuclear granulocytes in this respect even though they represent the largest 
proportion of leukocytes and are an abundant source of ROS during haemarthrosis. 
 
 
1.2. Reactive oxygen species in the pathomechanism of haemarthrosis 
 
From the early 30s, respiratory burst and reactive oxygen species (ROS)–mediated 
reactions have gradually become a focus for scientific interest. Nowadays it is generally 
accepted that ROS play important roles not only in the host defence mechanisms but also in 
ageing and numerous disease states. Thus it is not surprising that new findings from free 
radical research have shed light on the novel role of both the iron and PMNs in the 
pathomechanism of degenerative arthropathies, prompting new directions for research in 
haemarthrosis. 
Several studies report that iron is the most likely to stimulate hydroxyl generation and 
other radical reactions in vivo. Such reactive species are in turn able to attack the plasma 
membrane, mitochondria and DNA. This leads to interruption of cellular integrity, 
impairment of cellular energy homeostasis, alterations in the genetic code and finally 
amounting fatal injury to the cell. 
According to Halliwell and Gutteridge, when haemoglobin reacts with hydrogen 
peroxide produces a reactive species, most likely ferril radicals that can degrade DNA and 
stimulate lipidperoxidation. Moreover reaction of heme protein with excess of hydrogen 
peroxide can cause heme degradation and release of iron ions from the protein, followed by a 
Fenton reaction. 
On the basis of all above, besides direct matrix damaging potential of iron both RBC-
derived ferrous and ferric ion as well as haemoglobin may act as a catalyst for ROS producing 
reactions in the intraarticular microenvironment. Therefore their contribution in the acute 
haemarthrosis induced cartilage damage may be considered. 
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There is proof of non-mitochondrial respiratory burst in all phagocytes – PMNs, 
monocytes, eosinophils, and lung and peritoneal macrophages - due to activation of the 
membrane bound NADPH-oxidase. However owing to their high number, PMNs are thought 
to be influential cellular participant in cartilage damage. Indeed, there is a large body of 
evidence that following activation PMNs produce large variety of reactive oxygen 
metabolites, which are able to attack all components of cartilage tissue. 
 
 
1.3 Our hypothesis regarding the pathomechanism of acute haemarthrosis 
 
The mechanisms detailed above can undoubtedly come to play during chronic 
haemarthrosis as well. However the lack of repeated bleeding episodes and the consequently 
absence of severe synovitis as well as the brief duration of the unfavourable environment (the 
70-80 percent of RBCs are eliminated from the joint within 4-5 days enhance the importance 
of PMN and ROS-mediated pathways during acute haemarthrosis. According to our 
hypothesis PMNs are activated by the thrombocyte and endothelial-derived mediators 
released following the vascular injury. These leukocytes produce enzymes, cytokines and 
ROS that may induce production of similar factors in the chondrocytes and synovial cells via 
paracrine as well autocrine pathways. On the other hand, ROS and enzymes directly attack all 
components of the articular tissues.  
In order to provide support for our hypothesis, in vitro and clinical investigations were 
conducted to further clarify the following: 
 
1. Extent of activated PMNs and iron mediated chondrocyte damage under in vitro 
conditions. 
2. Do the PMNs engender oxidative stress on chondrocytes? 
3. Are the PMNs activated during clinical presentations of acute heamrthrosis? 
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2. EXTENT OF ACTIVATED PMNS AND IRON MEDIATED 
CHONDROCYTE DAMAGE UNDER IN VITRO CONDITIONS 
(First series of experiments) 
 
 
Regarding acute HA, there is yet relatively little data available on its pathomechanism 
despite being more common than the chronic form. The key to the pathological damage lies in 
changes of intra-articular fluid. There are of course significant differences between the 
constituents of synovial fluid and blood, which is rich in red blood cells (RBC) and 
polymorphonuclear leukocytes (PMN). Previous studies by Roosendal et al. have suggested 
that RBC and monocytes are responsible for such damage. Furthermore abundant data exists 
to suggest that PMN-derived reactive oxygen species (ROS) can damage a wide range of 
cellular components leading to cell death. In addition RBC-derived ferrous ion, a known 
participant of Fenton reaction, can also lead to the formation of highly reactive hydroxyl 
radical. 
This in vitro study was aimed to investigated interaction between some proposed key 
participants in the pathogenic processes following intraarticular bleeding. Thus the cytotoxic 
effects of PMN-derived ROS and increased quantity of ferrous ion on cultured chondrocytes 
were evaluated. Since DNA is also targeted by ROS, we hence investigated whether short-
term chondrocyte exposure to PMN causes histologically detectable DNA lesions. 
 
2.1. Materials and methods 
 
Animal preparation. Three healthy Yorkshire pigs (35-40kg) were used as blood 
donors. Each animal was subjected to an overnight fast and was sedated with ketamine 
(15mg/kg), induced with pentobarbitone and maintained on 1.5-% halothane inhalation. 
Following anaesthesia a silicon catheter was inserted into the jugular vein. The drain was led 
out on the posterior surface of the neck facilitating blood-sampling procedure.  
Chondrocyte isolation was carried out on ten healthy Yorkshire pigs, weighting 20-
25kg. These animals were sedated with ketamine (15mg/kg) and euthanased with intra cardiac 
injections of sodium pentobarbital (120mg/kg). All animal procedures were performed in 
accordance to the International Guiding Principles for Animal Research. 
Isolation and culturing of chondrocytes from pigs. Whole thickness cartilage was 
dissected from the articular surfaces of knee joint. The cartilage pieces were chopped and the 
chondrocytes freed from their extra-cellular matrix by digestion On the basis of the viability, 
1x106 living chondrocytes were seeded on each of the 12-well plastic culture plates and 
incubated in humidified 95% air and 5% CO2 mixture at 37°C Living chondrocytes (20x106) 
from the same source, were placed separately on 75cm2 plastic culture flasks and cultured as 
above for histological examinations.  
 Isolation of PMN. EDTA anticoagulated blood was sedimented with dextran and 
gently hemolised to remove the erythrocytes. The white pellet obtained after repeated 
centrifugation was suspended in glucose containing modified Dulbecco’s buffer and spun 
against gradient separator medium. Finally, the pellet consisting of about 95% PMN was 
suspended in cold buffer as above. After cell counting and viability estimation the required 
amount of cells were used in the experiment. 
Treatment of chondrocytes and measurements of cytotoxicity. Each well of culture 
plates were filled with either newly isolated PMN suspension or hydrogen peroxide as well as 
ferrous-sulphate or ferrous-sulphate with 107PMN/2ml PMN. The antioxidant Trolox was 
applied together with PMN to evaluate the effect of PMN-derived free radicals. In order to 
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exclude the non-specific lactate dehydrogenase (LDH) release reference populations of lysed 
and untreated chondrocytes as well as untretaed PMN and PMN in the presence of 0.1mM 
ferrous-sulphate were used. Finally, 0.2µg/ml phorbol 12-myristate 13-acetate (PMA) a PMN 
stimulating agent was added to each well. After 30 minutes of pre-incubation and thereafter 
the media were sampled every second hour for a total of six hours. The released LDH content 
of each sample was determined using CytoTox96® Assay kit. The following equation was 
used for determination of cytotoxicity.  
 
% Cytotoxicity = (ODtreated chondrocytes–ODchondrocytes spontaneous–ODPMN spontaneous (optional)) x100 
(ODlysed chondrocytes–ODchondrocytes spontaneous) 
 
 Histological examinations. Chondrocytes, in the presence of PMN (treated groups), 
and alone (control groups) were co-incubated. At the end of the experimental period cells 
were washed, fixed with paraformaldehyde and stained with Leishman stain as well as 
subjected to immunohistochemical (TUNEL) investigations. The samples were analysed 
semiquantitatively by light microscopy and an image analyser.  
Statistical evaluation. The experiments were performed on separate populations of 
chondrocytes, which were randomly allocated to various groups. The mean values of LDH 
and the standard errors are presented on the charts. One-way ANOVA test was used to define 
the significance between the mean values. A p-value of less than 0.05 was considered 
statistically significant. 
 
2.2. Results 
 
Cytotoxic effect of activated PMNs. The injurious effect of PMA-activated PMN on 
chondrocytes was tested by the measurement of LDH leakage, which is strongly correlated to 
the cellular damage. The cytotoxicity began to rise promptly and significantly following the 
addition of activated PMN. This trend peaked to 48.1±2.3 percent around the fourth hour of 
the experiment and slightly declined in the following two hours. The cytotoxic effect of 
hydrogen peroxide developed more slowly and increased continuously up to 46.4± 3.1 percent 
by the end of the examined period.  
 Involvement of free radicals in the PMN-mediated cytotoxicity. In order to explore the 
proportion of ROS in the granulocyte cytotoxicity the co-incubation was performed in the 
presence of Trolox, which is a cell permeable and water-soluble derivative of vitamin E with 
potent antioxidant property. It was found that Trolox significantly decreased the harmful 
effect of PMN in a dose dependent manner. 
 Role of increased amount of ferrous ion. The contribution of iron to chondrocyte 
damage was investigated using ferrous sulphate solutions (0.1-1.0mM final concentration), 
during the incubation. With ferrous sulphate alone the LDH release was insignificant. 
Likewise there was no significant difference between the PMN-mediated cytotoxicity 
measured in the presence or the absence of 0.1mM ferrous sulphate. Repeating the experiment 
without cells, no significant interference was noted between iron and the test kit or LDH. 
 Histological investigations. Since the chondrocytes were obtained from full thickness 
cartilage, the population might have contained various kinds of chondrocytes from the 
tidemark zone up to the superficial layer. Noticeable reduction in chondrocyte number was 
revealed in the treated groups as compared to the control. Polygonal and basophilic nucleated 
round shaped cells were found which showed remarkable variability in their size in both 
slides. The uniformly sized and shaped PMNs with their well known segmented nuclei were 
practically absent on the co-incubated sections as a consequence of shaking and rinsing 
procedures.  
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Lesions of chondrocyte genomic DNA were revealed by TUNEL reaction in PMN 
treated populations of chondrocytes. On the slides derived from the treated groups the ratio of 
DAB positive cells significantly exceeded the controls with respective values of 
30.696±2.72% and 2.03±0.27%.  
 
2.3. Discussion 
 
 Based on the approximate cellular ratio occurring under common clinical settings of 
acute HA, in vitro investigations were performed in order to evaluate the individual and 
common role of these proposed factors in the pathomechanism of HA. In this study we have 
shown that activated PMN are remarkably cytotoxic to chondrocytes. This cytotoxicity 
propagated more rapidly than the effect of hydrogen peroxide, almost equalling that of 10-4M 
H2O2. The additional effects of PMN-derived enzymes and other mediators could explain the 
difference between the kinetics of these processes. Detrimental role of PMN-derived ROS is 
confirmed by the fact that the antioxidant (Trolox) was able to significantly suppress the PMN 
cytotoxicity. On the other hand the partial cytotoxicity in Trolox treated groups underlines the 
importance of other PMN-derived factors that may have an injurious role. 
 Despite to several data form the literature on the subject, we did not observe a 
significant effect of increased ferrous ion concentrations on chondrocyte destruction. 
Surprisingly, an increased dose of Fe2+ also failed to influence PMN-derived cytotoxicity. 
This outcome correlates with results by Bates et al.. It is suggested that the consequent 
increase in Fe2+ has a subordinate pathogenic role in the early, ROS-mediated phase of acute 
haemarthrosis.  
Histological investigations were done on cultured cells to disclose the morphological 
signs of PMN-mediated chondrocyte injury. In our study, using activated PMN as appropriate 
source of ROS, the TUNEL postive cell ratio was approximately 30% after the 6 hour long 
procedure. Thus, our results proved that PMN resulted in DNA lesions in chondrocytes. These 
findings correlate with the observation that single and short-term exposure to leukocytes and 
RBCs is able to cause longterm inhibition of proteoglycan synthesis on chondrocytes. 
 In summary, although the artificial conditions are a limitation of this study, simulating 
an in vitro model of haemarthrosis was not our intention. Nonetheless we can conclude that 
activated PMN-derived ROS have significant cytotoxic potential against chondrocytes under 
in vitro conditions. Due to their potential and their dramatically enhanced presence in the 
articular cavity following acute HA, PMN are hypothesised to be a major culprit in the 
underlying pathomechanism of cartilage damage. The histological changes also substantiate 
our assumption that PMN lead to DNA lesions on chondrocytes. These results also raise the 
prospect of delayed (apoptotic?) consequences following acute traumatic HA. Although iron 
is claimed to be a key player in HA, its short-term role in chondrocyte degradation is 
controversial and its possible importance in the acute HA requires further investigations.  
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3. DO THE PMNS ENGENDER OXIDATIVE STRESS ON 
CHONDROCYTES ? 
(Second series of experiments) 
 
 
Intra-articular bleeding leading to articular damage is a well-established clinical entity. 
Several studies have documented the importance of synovial and blood-borne factors, such as 
inflammatory mediators and lysosomal enzymes, as contributors of this destructive process.  
Although deleterius effects of such agents on cartilage tissue have been proven in 
numerous studies, specific biochemical markers indicative of the degree of oxidative stress in 
chondrocytes, evoked by activated PMNs, have previously not been studied in this regard. 
Oxidative stress is described as a condition where excessive ROS production overwhelms the 
antioxidant defences. Reduced glutathione (GSH), is an integral element in this antioxidant 
defence, one that is depleted during oxidative stress. On the other hand superoxide dismutase 
(SOD), another member of the endogenous antioxidant system, demonstrates compensatory 
increase in activity following exposure to bursts of superoxide radical. Furthermore it has 
been proven that the detection of lipid peroxidation via measurements of malondialdehyde 
(MDA) and 4-hydroxy-2 (E)-nonenal (4-HNE) levels, is a suitable indicator for ROS-
mediated membrane damage. Thus monitoring the above parameters is considered appropriate 
in evaluating oxidative stress. 
 
3.1. Materials and methods 
 
Animal preparation. (see at 2.1.) 
Isolation and culturing of chondrocytes from pigs. (see at 2.1.).  
Isolation of PMNs. (see at 2.1.) 
Treatment of chondrocytes.. On the basis of viability, 20x106 healthy chondrocytes 
were seeded on 75cm2 plastic culture flasks and incubated. Except for the control populations 
(Group I.), the media were either supplemented with a suspension of isolated PMNs (Group 
II.), or freshly prepared hydrogen peroxide solution (10-4M final concentration, Group III.), as 
a controlled source of ROS. Finally 8µg phorbol 12-myrsistate 13-acetate (PMA) as PMN 
stimulator agent was added to each flask. Throughout the experiments, the flasks were 
incubated at 37°C and continuously agitated on a vibrating table at 60 rpm. 
Measurement of free radical mediated changes. Following six hours of incubation, the 
cells were washed removing dead chondrocytes and PMNs. The remaining cells were 
collected with rubber cell-scraper and homogenized by repetitive freezing/thawing and the use 
of a plastic pestle. The cell homogenate was sampled for biochemical analysis. 
 Changes in the endogenous scavenging status were characterized by the measurement 
of reduced glutathione (GSH) concentration and superoxide dismutase (SOD) activity of the 
samples using colorimetric assay kits.  
 The immediate harmful effect of ROS on cell membranes was evaluated by assessing 
the degree of lipid peroxidation using relevant assay kit. Changes in the levels of 
malondialdehyde (MDA) and 4-hydroxyalkenals contents of the specimens were assessed. 
 Histological examinations. (See at 3.1). 
Statistical evaluation. In each experiment the populations of chondrocytes derived 
from the same animal were randomly divided into different groups (namely control and PMN 
or H2O2 treated). The mean values of the different parameters and the standard errors are 
presented. Non-parametric Sign test was used to define the significance between the mean 
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values of the control and treated groups of chondrocytes. A p-value of less than 0.05 was 
considered statistically significant. 
 
3.2. Results 
 
Monitoring the endogenous scavengers. Results show that intracellular levels of GSH 
(n=8) declined significantly following co-incubation with either H2O2 (1.36±0.09 µg/mg, 
p=0,008) or PMNs (1.13±0.14 µg/mg, p=0,008) as compared to controls (1.86±0.12 µg/mg). 
The difference between the differently treated groups was not significant. 
Conversely SOD activity (n=11) in treated cells (PMNs: 24.57±2.34 U/mg, p=0,001; 
H2O2: 23.61±1.82 U/mg, p=0,001) showed considerable elevation versus control cells 
(18.49±1.77 U/mg). Although the effect of hydrogen peroxide was less profound than that of 
PMNs, the difference again was not statistically significant. 
Measurement of lipid peroxidation. The data obtained from the simultaneous 
measurement of MDA and 4-HNE (n=11) indicate significant increase in lipid peroxidation in 
both groups of treated cells (PMNs: 2.62±0.84 nM/mg, p=0,012; H2O2: 3.12±1.01 nM/mg, 
p=0,001) compared to the control group (1.71±0.52 nM/mg). Again the difference between 
the two treated groups was not significant. 
Histological examinations. Whole thickness cartilage was used for obtaining 
chondrocytes, so the populations might have represented all kinds of cells from the superficial 
layer to the tide mark zone. Polygonal and round shaped cells with their basophilic nuclei 
were present in both control and co-incubated (treated) slides. Marked reduction in 
chondrocyte population was seen on slides belonging to treated groups. Due to the shaking 
and rinsing procedures, similarly sized PMNs with their typical segmented nuclei were 
practically absent on the sections and therefore could not have interfered with the biochemical 
analysis of ROS-mediated chondrocyte damage. 
 
3.3. Discussion 
 
Recent studies draw attention to the fact that blood itself can harm the cartilage and 
that its direct effect precedes the consequences of synovial inflammation. Several studies have 
addressed the damaging role of activated PMNs on cartilage matrix and chondrocytes. In spite 
such investigations, little is known about the effect of a PMN-evoked oxidative stress on 
chondrocyte.  
Since oxidative stress disrupts the balance of endogenous scavengers and antioxidants, 
investigating alterations in these systems would appropriately reflect the degree of stress 
caused by ROS. Reduced glutathione, due to its nucleophilic and reducing properties, plays a 
central role in the cellular antioxidant defence mechanisms. Evidence for a reduction of this 
antioxidant provides support for an increased ROS activity during such process. In our study 
We observed a significant decline in intracellular GSH concentration in treated samples, an 
indication of the presence of such reactive species.  
Superoxide dismutase is an intracellular metalloprotein, which transforms superoxide 
anion into H2O2 and oxygen, thus eliminating free radicals. Fridovich and other investigators 
have reported that increased production of superoxide radical induces SOD activation. 
Therefore the significant elevation in SOD activity in both our treated groups is considered to 
be in response to increased quantity of O2.- radical derived from either activated PMN or the 
reaction between H2O2 and .OH, which also results in superoxide radicals.  
Lipid peroxidation is a well-known mechanism of cellular injury in both plants and 
animals. On the basis of the immediate deleterious effects of ROS on chondrocyte, we 
evaluated the process of lipid peroxidation in this model. Significant elevation of MDA/4-
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HNE levels in both PMN and H2O2 treated groups suggest increased ROS-mediated lipid 
membrane injury. This fact demonstrates not only the presence reactive species but also their 
consequence, namely oxidative injury to chondrocytes. 
In summary our in vitro study has clearly proven the presence of oxidative stress and 
chondrocyte injury elicited by activated PMNs through demonstrating alterations in specific 
markers indicative of such a process. Although the artificial conditions are a limitation of this 
study, simulating an in vitro model of haemarthrosis was not the author’s intention. 
Nonetheless these observations provide evidence that short-term exposure to activated PMNs 
can lead to oxidative injury of chondrocytes, it is arguable that in clinical situations of 
haemarthrosis, PMNs and ROS may also contribute to cartilage damage.  
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4. ARE THE PMNS ACTIVATED DURING CLINICAL 
PRESENTATIONS OF ACUTE HAEMARTHROSIS? 
(Third series of experiments) 
 
 
In vitro investigations have proven that single or a limited number of bleeding 
episodes result in cartilage damage, in which cytotoxic oxygen metabolites derived from the 
interaction between mononuclear cells and red blood cells are supposed to play a role. These 
results support the importance of the impact of a single haemarthrotic episode. Similarly our 
previous in vitro investigations suggest a key role of activated PMNs in the pathomechanism, 
yet the question whether leukocytes are activated during acute, clinical haemarthrosis remains 
unanswered.  
This study aimed to assess the leukocyte activation and the production of leukocyte-
derived reactive oxygen species (ROS) during acute haemarthrosis. Enhanced expression of 
various surface antigens is a known characteristic of leukocyte activation, especially 
polymorphonuclear granulocytes (PMN), which are reported to produce highly toxic ROS. 
Subsequent to identifying PMN activation and ROS production we intended to gain data 
regarding the impact of leukocyte activation and its place in the hierarchy of pathogenic 
events in acute haemarthrosis.  
 
4.1. Materials and methods 
 
Subjects. Twenty-two patients admitted to the Department of Traumatology and Hand 
Surgery (affiliated to the Medical Faculty of University of Pécs) with acute traumatic knee 
injury were included in this study. There consisted 18 males and 4 female ranging from 18 to 
75 (mean 44) years in age. All patients underwent a physical examination and X-ray imaging 
before their articular effusions were evacuated under sterile conditions as a part of their 
treatment. The mean duration between the knee injury and joint aspiration was 18 hours with 
a range of 1 to 60 hours. Corresponding venous blood samples were obtained from the cubital 
veins from all patients and all samples were placed in ice and immediately sent to the 
laboratory for fluorescent flow cytometric analysis and chemiluminometry.  
Preparation of leukocytes and flow cytometric analysis. Blood was treated with EDTA 
and cells sedimented with dextran and the erythrocytes were removed by hypotonic 
haemolysis. Appropriate amount of the whole leukocyte fraction was used for 
immunofluorescence staining with (FITC)-conjugated mouse anti-human CD11a, CD18 and 
CD97 mAbs. Binding of FITC-labelled antibodies to leukocytes was quantified both as the 
percentage of cells exhibiting specific FITC fluorescence and the mean channel fluorescence 
in arbitrary unit that exceeded non-specific background fluorescence. 
Luminol dependent whole blood chemiluminometry. Respiratory burst activity of 
leukocytes in corresponding samples of peripheral blood and joint effusion was measured by 
detection of ROS via modified chemiluminescence method published by Dandona et al. 
Lagtime and ROS producing capacity were calculated on the basis of the curve. 
Statistical evaluation. Results were expressed as means ± SD. Two-tailed Students 
paired t-test was used to compare differences between venous blood and joint-fluid leukocyte 
samples. A p-value of less than 0.05 was considered statistically significant. 
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4.2. Results 
 
Flow cytometry. 
Monocytes. Flow cytometric analysis of leukocyte populations derived from venous blood and 
joint aspirate failed to reveal any significant differences between the joint and venous samples 
with regards to the expression of the CD97 on monocytes or the proportion of CD11a, CD18 
and CD97 positive cells. There was an enhanced expression of CD18 on these cells but it did 
not reach significant levels (p=0.094). However a significant decline was found in case of 
CD11a expression in the articular monocytes compared to peripheral cells (p=0.00167). 
Polymorphonuclear Granulocytes (PMN). Investigations on the expression of CD18 
and CD97 surface antigens showed significantly increased mean density (CD18: p=0.00945; 
CD97: p=0.00338) of these markers on the joint-derived PMNs comparing to the venous 
samples. On the other hand there were no marked difference between effusion and peripheral 
populations either in case of CD11a expression or the proportion of mAb positive PMNs 
regarding each antigen. 
Lymphocytes. Paired analysis of peripheral blood and synovial effusion samples 
demonstrated a significant increase in the number of CD97 positive lymphocytes in the joint 
derived group (p=0.000149). There was no significant alteration regarding other measured 
parameters. 
 
Chemiluminometry 
Comparative assessments of corresponding samples derived from cubital vein and 
articular cavity revealed a significantly enhanced production of ROS (p= 0,0146) and 
markedly decreased lag time (p= 0,00272) in case of leukocytes from the latter group. 
 
4.3. Discussion 
 
Currently it is believed that the inflammatory changes of synovial tissue lead to 
cartilage damage. However more recent studies have shown that changes in the articular 
cartilage which precede synovitis may initiate the joint destruction. Moreover such changes 
occur almost immediately after a brief exposure to blood, suggesting that even a single 
intraarticular bleeding event may be harmful. 
In spite of the numerous studies detailing the importance of different cellular and non-
cellular mediators in the pathogenesis of haemarthrosis, the initiating factor remains unclear. 
The normal synovial fluid contains only few leukocytes, less than 200-300 cells/mm3. This 
population is dramatically altered during haemarthrosis and there is an obvious increase in the 
number of leukocytes. These cells have the ability to produce catabolic enyzmes, cytokines 
and reactive oxygen species following activation by different proinflammatory mediators such 
as platelet activating factor (PAF), thromboxan-A2 and leukotriens (LTB4). These activators 
are released from the endothelial cells and from the locally recruited platelets as a 
consequence of the intra-articular vascular injury.  
In this clinical study we aimed to explore the importance of leukocytes as mediator in 
the inflammatory reactions and the activation of cartilage destruction during acute 
haemarthrosis. Hence a comparison was made in the expression of alpha-chain of LFA-1 
(CD11a), the common beta-chain of β-2 integrins (CD18) and in the leukocyte activation 
antigen (CD97) between leukocytes derived from traumatic knee effusion and those derived 
from the peripheral blood.  
The significantly decreased expression of CD11a on joint-derived monocytes suggests 
a subordinate role of LFA-1 during haemarthrosis-associated leukocyte activation. Similar 
results have been reported by Jones et al., who compared the CD11a and CD11b/CD18 
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expression on PMNs derived from synovial fluid and systemic circulation in patients with 
rheumatoid arthritis. The significant increase of CD18 and CD97 expression on PMNs 
derived from haemarthrosis compared to corresponding venous blood samples provides good 
evidence of PMN activation. The elevation in the proportion of CD97 positive lymphocytes in 
the articular cavity as compared with systemic blood suggests that lymphocytes also might 
have an important role in the early inflammatory reactions in acute haemarthrosis. Since 
ligand binding to CD97 leads to activation of adenylate cyclase and increase of intracellular 
cAMP level, it is possible that such process leading to a higher metabolic activity, augmenting 
the cellular inflammatory response at the binding site. Moreover the increased expression of 
CD18, as opposed to unchanged density of CD11a on PMNs suggest an upregulation of 
integrins that is most likely Mac-1 as it found in rheumatoid arthritis.  
Production of ROS following activation is characteristic of several immune cells, 
especially of PMNs. Whole blood chemiluminescence assay has proven to be a rapid, simple 
and reliable technique for estimation of ROS generating capacity of leukocytes. Our 
investigations revealed that joint-derived leukocytes required significantly less time to 
generate ROS, and at higher rate than the corresponding peripheral white blood cells, in other 
words leukocytes from the articular cavity had been sensitised.  
In summary, our findings demonstrate enhanced expression of CD18 and CD97 on 
PMNs and increased number of CD97 positive lymphocytes in articular effusions of patients 
with acute traumatic haemarthrosis. On the other hand, leukocytes from the same samples 
showed significantly higher ROS production with shortened lag time. All these suggest 
marked leukocyte activation as part of the clinical process. Since the earliest synovial changes 
are recorded by 4 days following single haemarthrosis, it is likely that leukocyte activation 
precedes it. The importance of PMNs and lymphocytes in the regulation of inflammatory 
mechanisms and in cytotoxicity is well recognised. Therefore it is believed that these cells 
provide the missing link in the chain of events leading to the onset of degenerative events 
following acute haemarthrosis. 
 
 
 
 
 
 
 
 
5. CONCLUSIONS AND CLINICAL RELEVANCE 
 
The lack of unambiguous data from human investigations proving that single 
intraarticular bleeding episode is responsible for chronic disabilities, brings to question 
whether acute haemarthrosis is really dangerous under clinical conditions. Of course we have 
to beware when drawing direct conclusions from in vitro investigations. However it is beyond 
doubt that blood itself harms the cartilage as verified by several in vitro and in vivo studies. 
Our results also support this concept and draw the attention to the PMNs and ROS as 
important participants in the pathogenic processes. Thus acute haemarthrosis can be viewed as 
a form of stress, which may have long lasting sub-clinical effect on the joint. However 
combined with other factors (e.g.: abnormal loading, immobilisation or repeated episodes) 
their concerted effects can lead to clinically detectable joint injury. Thus acute haemarthrosis 
may be considered a risk factor for joint damage the elimination of which is essential in order 
to prevent further articular destruction. 
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6. NOVELTIES 
 
 
• The first series of experiments highlighted the importance of PMN-derived ROS in 
predisposing chondrocytes to cytotoxic processes and DNA damage upon exposure to 
abundant activated PMN. The applied in vitro conditions such as the cellular ratio and the 
concentration of reacting agents reflected the clinical settings in a certain degree, thus our 
results underline the importance of PMNs and ROS in chondrocyte damage as is probably 
the case in acute haemarthrosis.  
 
• In the second series of experiments we demonstrated for the first time that activated 
PMNs are able to exert oxidative injury on chondrocytes in vitro. Our results confirm 
previous suggestions that PMN-derived ROS contribute to cartilage degradation in acute 
haemarthrosis. Moreover these results support the importance of ROS scavenging and 
PMN-inhibiting drugs as therapeutic alternatives in the treatment of this condition. 
 
• The clinical trial provided clear evidence for leukocyte activation during acute 
haemarthrosis, a fact that had remained disclosed so far. Our previous in vitro 
observations regarding the deleterious role of PMNs have also been confirmed by this 
trial. 
 
• Also novel to this work was the review of therapeutic alternatives and its proposed 
revision regarding especially the routinely applied plaster immobilisation in case of acute  
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